Name | SR0987 |
---|---|
Synonyms |
2-Chloro-N-[4-(1,1,1,3,3,3-hexafluoro-2-hydroxy-2-propanyl)phenyl]benzamide
Benzamide, 2-chloro-N-[4-[2,2,2-trifluoro-1-hydroxy-1-(trifluoromethyl)ethyl]phenyl]- MFCD02693203 |
Description | SR0987 is a RORγt agonist, with an EC50 of 800 nM. |
---|---|
Related Catalog | |
Target |
EC50: 800 nM (RORγt)[1]. |
In Vitro | SR0987 clearly shows a concentration dependent induction of reporter gene expression with an EC50 of ~800nM. SR0987 treatment results in a statistically significant reduction of the surface expression of PD-1 whereas desmostrol treatment shows no effect. Treatment with SR0987 and or desmosterol results in a trend towards increased IL17 production[1]. |
References |
Density | 1.5±0.1 g/cm3 |
---|---|
Boiling Point | 378.8±42.0 °C at 760 mmHg |
Molecular Formula | C16H10ClF6NO2 |
Molecular Weight | 397.699 |
Flash Point | 182.9±27.9 °C |
Exact Mass | 397.030426 |
LogP | 4.36 |
Vapour Pressure | 0.0±0.9 mmHg at 25°C |
Index of Refraction | 1.541 |
Storage condition | 2-8℃ |